“Our innovative cyanine-carborane salts offer a targeted option with reduced side effects for patients with aggressive breast ...
Improved DL-PDT Effectiveness: CAL pre-treatment boosted the therapeutic impact of daylight photodynamic therapy (DL-PDT) for ...
Scientists are working to create a new light-activated 'smart' bomb to treat aggressive breast cancer. The new light-sensitive chemicals called cyanine-carborane salts are used in photodynamic therapy ...
A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...
The global light therapy market is on an upward trajectory, projected to reach USD 1,012.1 million by 2024, and is anticipated to grow at a CAGR of 4.6% from 2024 to 2034, reaching an impressive USD 1 ...
AIE is a unique photophysical phenomenon, and its distinctive luminescence properties have demonstrated significant potential ...
Soligenix is enrolling patients in its FLASH2 study, with a formal interim analysis anticipated early in 2026. <li /> SNGX's HyBryte is a ...
Photodynamic therapy (PDT) has emerged as a promising minimally invasive treatment modality in cancer therapy, combining photosensitizers, light, and oxygen ...
A new comparison of approval data for first-in-class drugs approved by the US FDA and the EMA revealed that the FDA is more ...
Biofrontera Inc. (NASDAQ: BFRI) Q4 2024 Earnings Call Transcript March 21, 2025 Biofrontera Inc. misses on earnings ...
SNGX READ THE FULL SNGX RESEARCH REPORT Business Update CiVaxâ„¢ Booster Enhances Protection from COVID-19 in NHPs On March 25, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback